http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108295318-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2430-36 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-145 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-042 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-04 |
| filingDate | 2018-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-108295318-B |
| titleOfInvention | Temperature-sensitive injectable lacrimal passage suppository and preparation method thereof |
| abstract | The invention discloses a temperature-sensitive injectable lacrimal passage suppository and a preparation method thereof, and is characterized in that: the injectable lacrimal passage suppository is prepared from a temperature-sensitive composite hydrogel material, is injected into a lower lacrimal canaliculus orifice of eyes of a human or an animal under the liquid state, and is solidified by depending on the body temperature of the human or the animal to block the lower lacrimal canaliculus orifice, wherein the temperature-sensitive composite hydrogel material is prepared by poloxamer407, poloxamer 188 and water, and a viscosity enhancer and/or a strength enhancer are/is added according to the needs. The injectable lacrimal passage suppository disclosed by the invention has good flow at low temperature, can be injected into the lacrimal canaliculus of a human or an animal through an injector, and can be quickly solidified by means of the body temperature of the human or the animal to block the lacrimal canaliculus to play a role in relieving xerophthalmia. |
| priorityDate | 2018-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 27.